Table 1 Ketamine and Psilocybin-induced downstream long-lasting sustained change events.
Drug | Model | Experimental objects | Downstream long-lasting sustained change events | Span | Ref |
---|---|---|---|---|---|
Ketamine | CUS | C57BL/6J mice | Depression-related behaviors; Dendritic spine density and dendritic spine morphology in prefrontal cortex (PFC), amygdala, and hippocampus | 8 d | [29] |
Nrf2 KO | C57BL/6 mice | Depression-related behaviors; TrkB signaling pathway in PFC; synapse-associated proteins GluA1 and PSD-95 in PFC | 7 d | [19] | |
Anxiety disorders combined PTSD | Wistar Kyoto rat | Avoidance-related behaviors; Hippocampal synaptic plasticity | 21 d | [31] | |
Middle cerebral artery occlusion combined chronic unpredicted mild stress | Sprague-Dawley rat | Depression-related behaviors; NMDAR/CaMKII signaling pathway; Synaptic plasticity in the hippocampal dentate gyrus | 7 d | [33] | |
Chronic pain | C57BL/6J mice | Depression-related behaviors; T cell lymphoma invasion and metastasis 1 (Tiam1); Synaptic structure and functional plasticity in Anterior cingulate cortex (ACC) neurons | 3 d | [32] | |
Chronic CORT combined with repetitive restrain | C57BL/6J mice | Depression-related behaviors; Postsynaptic dendritic spines on prefrontal projection neurons | 21 d | [30] | |
- | CA1 region of mice hippocampal slices | NMDA receptor ion channels; K+ channels; Postsynaptic neuronal population spike amplitudes | 2 h | [18] | |
- | Mice mesencephalic and human induced pluripotent stem cells-derived DA neurons | AMPAR/mTOR/BDNF signaling pathway; Synaptic structural plasticity | 3 d | [36] | |
- | Swiss mice | BDNF and GFAP protein expression in PFC; Neuroplasticity | 30 d | [34] | |
- | C57BL/6 mice | Depression-related behaviors; NRG1/ ErbB4 signaling in parvalbumin-expressing (PV) neurons in the PFC; Neuroplasticity | 7 d | [35] | |
Ketamine and guanosine | - | Swiss mice | Depression related behaviors; Dendritic spine density, mTORC1-dependent mechanisms, and synapse-associated proteins in the DG of the ventral hippocampus and the PFC | 1 d | [45] |
Psilocybin | Major depressive disorder | Human | EEG θ power amplitude; Neuroplasticity | 14 d | [38] |
- | Human | Resting-state functional connectivity; Emotions and brain plasticity | 30 d | [37] | |
- | C57BL/6 J mice | Stress related behaviors; Excitatory neurotransmission; synaptic rewiring | 30 d | [39] | |
 | Danish slaughter pig | Hippocampal synaptic vesicle protein 2 A (SV2A); Increased persistent synaptogenesis | 7 d | [40] | |
Ketamine and scopolamine | - | C57BL/6 J mice | Depression related behaviors; Phosphorylation of methyl CpG-binding protein 2 (MeCP2); BDNF protein expression; Synaptic plasticity | 7 d | [46] |
Ketamine and (2 R,6 R)-HNK | - | C57BL/6 mice | Function of AMPARs in the nucleus ambiguus; Altered Synaptic Plasticity in Brain Regions Associated with Rewarding Behavior | 7 d | [41] |
(2 R,6 R)-HNK | Learned helplessness (LH) | Sprague-Dawley rats | Depression-related behaviors; Glutamatergic transmission and surface GluR1 expression in the ventrolateral periaqueductal gray (vlPAG); Frequency and amplitude of miniature excitatory postsynaptic currents (mEPSCs) in the vlPAG | 21 d | [43] |
- | midbrain dopaminergic neurons | Dendrite outgrowth | 3 d | [44] | |
- | C57BL/6J mice | BDNF/TrkB/mTORC1 signaling in the PFC; Synaptic function | 5 d | [42] |